Liang Gong Selected Research

Breast Neoplasms (Breast Cancer)

1/2019	B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells.
1/2018	Diminished gray matter density mediates chemotherapy dosage-related cognitive impairment in breast cancer patients.
1/2017	Altered resting-state hippocampal functional networks associated with chemotherapy-induced prospective memory impairment in breast cancer survivors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liang Gong Research Topics

Disease

40	Neoplasms (Cancer) 01/2024 - 01/2013
11	Lung Neoplasms (Lung Cancer) 01/2023 - 04/2012
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 07/2011
7	Carcinogenesis 12/2022 - 06/2018
7	Neoplasm Metastasis (Metastasis) 11/2021 - 04/2012
6	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2014
6	Cognitive Dysfunction 01/2019 - 01/2017
5	Infections 03/2023 - 10/2016
4	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2023 - 01/2021
4	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 01/2017
3	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 01/2017
3	Inflammation (Inflammations) 03/2023 - 01/2020
3	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2017
2	Pancreatitis 12/2023 - 01/2023
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 01/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 10/2012
2	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2013
2	Lung Injury 03/2022 - 01/2018
2	Stroke (Strokes) 01/2022 - 01/2021
2	Ototoxicity 01/2022 - 01/2022
2	Hypoxia (Hypoxemia) 07/2021 - 05/2021
2	Adenocarcinoma of Lung 10/2012 - 04/2012
1	Squamous Cell Carcinoma of Head and Neck 03/2024
1	Asthma (Bronchial Asthma) 01/2024
1	Hemangiosarcoma (Angiosarcoma) 01/2024
1	Sarcoma (Soft Tissue Sarcoma) 01/2024
1	Neuroblastoma 12/2023
1	Pleural Effusion (Pleural Effusions) 05/2023
1	Stomach Ulcer (Gastric Ulcer) 03/2023
1	Ulcer 03/2023
1	Mycoses (Diseases, Fungus) 03/2023
1	Sepsis (Septicemia) 01/2023
1	Stomach Neoplasms (Stomach Cancer) 11/2022

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 03/2023 - 01/2018
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
4	LigandsIBA 01/2023 - 01/2019
4	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2013
4	ApolipoproteinsIBA 01/2019 - 01/2017
4	Apolipoproteins E (ApoE)IBA 01/2019 - 01/2017
4	bisdemethoxycurcuminIBA 11/2015 - 07/2011
4	CurcuminIBA 11/2015 - 07/2011
3	CateninsIBA 03/2024 - 01/2017
3	AntibodiesIBA 01/2024 - 10/2021
3	Messenger RNA (mRNA)IBA 12/2023 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2020
3	Therapeutic UsesIBA 01/2021 - 01/2013
2	Indicators and Reagents (Reagents)IBA 03/2024 - 01/2013
2	ErbB Receptors (EGF Receptor)IBA 01/2024 - 11/2021
2	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2022
2	Dopamine (Intropin)FDA LinkGeneric 12/2023 - 01/2017
2	Polysaccharides (Glycans)IBA 03/2023 - 02/2022
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2019
2	Monoclonal AntibodiesIBA 01/2022 - 02/2021
2	Complement System Proteins (Complement)IBA 01/2022 - 10/2021
2	CarbohydratesIBA 01/2022 - 01/2020
2	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 10/2021
2	Neomycin FDA LinkGeneric 01/2022 - 01/2022
2	Single-Domain AntibodiesIBA 11/2021 - 02/2021
2	Mitochondrial DNA (mtDNA)IBA 07/2021 - 05/2021
2	IntegrinsIBA 01/2021 - 04/2012
2	Carcinoembryonic AntigenIBA 01/2020 - 01/2020
2	FumonisinsIBA 01/2019 - 01/2016
2	Antidepressive Agents (Antidepressants)IBA 08/2018 - 01/2018
2	Hormones (Hormone)IBA 02/2018 - 10/2014
2	P-SelectinIBA 10/2012 - 04/2012
1	Cetuximab (Erbitux)FDA Link 01/2024
1	Antineoplastic Agents (Antineoplastics)IBA 01/2024
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2024
1	AntioxidantsIBA 01/2024
1	anlotinibIBA 01/2024
1	ParaffinIBA 12/2023
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2023
1	Formaldehyde (Formol)FDA Link 12/2023
1	ElonginIBA 09/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2023
1	Adenosine DeaminaseIBA 05/2023
1	Ethanol (Ethyl Alcohol)IBA 03/2023
1	Niacin (Nicotinic Acid)FDA LinkGeneric 03/2023
1	Niacinamide (Nicotinamide)FDA LinkGeneric 03/2023
1	Vitamin B 6IBA 03/2023
1	Interleukin-10 (Interleukin 10)IBA 03/2023
1	Interleukin-6 (Interleukin 6)IBA 03/2023
1	Anthocyanins (Anthocyanin)IBA 03/2023
1	MicroRNAs (MicroRNA)IBA 03/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 01/2023
1	Adenosine Diphosphate (ADP)IBA 01/2023
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	PlatinumIBA 01/2023
1	olaparibIBA 01/2023
1	Exosome Multienzyme Ribonuclease ComplexIBA 12/2022
1	Acetates (Acetic Acid Esters)FDA Link 03/2022

Therapy/Procedure

11	Therapeutics 01/2024 - 01/2013
10	Immunotherapy 01/2024 - 01/2019
7	Drug Therapy (Chemotherapy) 01/2023 - 01/2017
3	Radiotherapy 01/2022 - 01/2017
2	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 01/2020
1	Patient Discharge 12/2023